Acadia Pharmaceuticals
ACAD
ACAD
297 hedge funds and large institutions have $7.4B invested in Acadia Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 80 increasing their positions, 95 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
14% less call options, than puts
Call options by funds: $39.2M | Put options by funds: $45.6M
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
16% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 95
Holders
297
Holding in Top 10
6
Calls
$39.2M
Puts
$45.6M
Top Buyers
| 1 | +$117M | |
| 2 | +$43.6M | |
| 3 | +$41.6M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$30.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$27.9M |
Top Sellers
| 1 | -$115M | |
| 2 | -$71.5M | |
| 3 | -$58.4M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$46.1M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$43.3M |